Merck’s decision to establish oncology as a standalone business unit is easy to describe and tempting to oversimplify. At ...

First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY ...

This article explores how tissue-based companion diagnostics leveraging immunohistochemistry approaches will help to select patients for targeted cancer treatments.

The 2 nd Next-Generation Conjugates Summit, designed to help you push the boundaries of bioconjugate drug development with next-generation payloads and formats to improve translation and show a ...

The 3rd Next-Generation Conjugates Summit (Boston | February 26-28, 2024) is the only event dedicated to showcasing conjugate drugs with novel payloads and formats, providing unrivalled access to 30+ ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...

For decades, scientists have believed that complex life began when two very different microbes joined forces, eventually ...

Complex cells are thought to be the result of a union between two ancient microorganisms, but scientists have long been ...

Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that ...

The most widely accepted scientific explanation for the arrival of all complex life on Earth has had an unsolved mystery at its heart. According to the theory, all plants, animals and fungi, known ...

The 2026 Forbes Healthcare Summit will convene the world's most influential leaders in healthcare, medicine and science.

Scientists propose that eukaryotes formed when an Asgard archaeon entered into a close partnership with an alphaproteobacterium. Over time, the two organisms became permanently linked. The ...